Subclinical signs in LRRK2 mutation carriers

被引:24
|
作者
Johansen, Krisztina K. [1 ,2 ]
White, Linda R. [1 ,2 ]
Farrer, Matthew J. [3 ]
Aasly, Jan O. [1 ,2 ]
机构
[1] St Olavs Univ Hosp, Dept Neurol, N-7006 Trondheim, Norway
[2] Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway
[3] Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada
关键词
Parkinson's disease; G2019S; N1437H; Premotor; Hyposmia; LRRK2-ASSOCIATED PARKINSONS-DISEASE; DOPAMINERGIC DYSFUNCTION; CLINICAL-DIAGNOSIS; PROGRESSION; ACCURACY; FEATURES; PHASE; RISK;
D O I
10.1016/j.parkreldis.2011.04.014
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Several non-motor features have been reported to precede the motor signs of Parkinson's disease (PD) by several years. However, the time of onset of non-motor and motor symptoms is still debated. Healthy individuals carrying a PD-related mutation are candidates for studying the earliest disease signs. Objectives: To describe clinically healthy family members of PD patients carrying a LRRK2 mutation (LRRK2-PD). Methods:A total of 47 family members of LRRK2-PD patients were included in the present study and were screened for the p.G2019S and p.N1437H substitutions in the LRRK2 gene. A standardized case report form was filled out in each case, including general medical evaluation, neurological examination with UPDRS, an olfaction test, mood, sleep and cognitive questionnaires. Results: Thirty-two study participants were positive, and 15 were negative for a LRRK2 mutation. Higher UPDRS motor scores, more frequent reports of urinary problems, and fewer hours of sleep were found in mutation carriers compared to non-carriers. The mutation carriers with UPDRS >= 8 were all aged over 50 years, had shorter overall sleeping hours, more frequent urinary and constipation problems, higher mood scores and body mass index. Deterioration of olfaction was not detected in either group. Conclusion: Healthy LRRK2 mutation carriers presented subclinical parkinsonian motor and non-motor signs in the apparent absence of olfactory loss. Longitudinal studies will determine whether these changes precede alterations detectable by neuroimaging. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:528 / 532
页数:5
相关论文
共 50 条
  • [1] Autonomic dysfunction in parkinsonian LRRK2 mutation carriers
    Tijero, Beatriz
    Gomez Esteban, Juan Carlos
    Somme, Johanne
    Llorens, Veronica
    Lezcano, Elena
    Martinez, Ana
    Rodriguez, Trinidad
    Berganzo, Koldo
    Jose Zarranz, Juan
    PARKINSONISM & RELATED DISORDERS, 2013, 19 (10) : 906 - 909
  • [2] Early Compensatory Mechanisms in LRRK2 Mutation Carriers
    Palermo, Giovanni
    Frosini, Daniela
    Antonini, Angelo
    Ceravolo, Roberto
    MOVEMENT DISORDERS, 2022, 37 (03) : 662 - 663
  • [3] Elevated LRRK2 autophosphorylation in brain-derived and peripheral exosomes in LRRK2 mutation carriers
    Wang, Shijie
    Liu, Zhiyong
    Ye, Tao
    Mabrouk, Omar S.
    Maltbie, Tyler
    Aasly, Jan
    West, Andrew B.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2017, 5 : 86
  • [4] Cerebrospinal fluid amyloid β and tau in LRRK2 mutation carriers
    Aasly, J. O.
    Shi, M.
    Sossi, V.
    Stewart, T.
    Johansen, K. K.
    Wszolek, Z. K.
    Uitti, R. J.
    Hasegawa, K.
    Yokoyama, T.
    Zabetian, C. P.
    Kim, H. M.
    Leverenz, J. B.
    Ginghina, C.
    Armaly, J.
    Edwards, K. L.
    Snapinn, K. W.
    Stoessl, A. J.
    Zhang, J.
    NEUROLOGY, 2012, 78 (01) : 55 - 61
  • [5] Higher urate in LRRK2 mutation carriers resistant to Parkinson disease
    Bakshi, Rachit
    Macklin, Eric A.
    Logan, Robert
    Zorlu, Musab M.
    Xia, Ning
    Crotty, Grace F.
    Zhang, Ellen
    Chen, Xiqun
    Ascherio, Alberto
    Schwarzschild, Michael A.
    ANNALS OF NEUROLOGY, 2019, 85 (04) : 593 - 599
  • [6] Imaging dopamine function and microglia in asymptomatic LRRK2 mutation carriers
    Morten Gersel Stokholm
    Alicia Garrido
    Eduardo Tolosa
    Mónica Serradell
    Alex Iranzo
    Karen Østergaard
    Per Borghammer
    Arne Møller
    Peter Parbo
    Kristian Stær
    David J. Brooks
    Maria José Martí
    Nicola Pavese
    Journal of Neurology, 2020, 267 : 2296 - 2300
  • [7] Imaging dopamine function and microglia in asymptomatic LRRK2 mutation carriers
    Stokholm, Morten Gersel
    Garrido, Alicia
    Tolosa, Eduardo
    Serradell, Monica
    Iranzo, Alex
    Ostergaard, Karen
    Borghammer, Per
    Moller, Arne
    Parbo, Peter
    Staer, Kristian
    Brooks, David J.
    Jose Marti, Maria
    Pavese, Nicola
    JOURNAL OF NEUROLOGY, 2020, 267 (08) : 2296 - 2300
  • [8] Sleep Aspects on Video-Polysomnography in LRRK2 Mutation Carriers
    Ehrminger, Mickael
    Leu-Semenescu, Smaranda
    Cormier, Florence
    Corvol, Jean-Christophe
    Vidailhet, Marie
    Debellemaniere, Eden
    Brice, Alexis
    Arnulf, Isabelle
    MOVEMENT DISORDERS, 2015, 30 (13) : 1839 - 1843
  • [9] Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriers
    Pachi, Ioanna
    Koros, Christos
    Simitsi, Athina M.
    Papadimitriou, Dimitra
    Bougea, Anastasia
    Prentakis, Andreas
    Papagiannakis, Nikolaos
    Bozi, Maria
    Antonelou, Roubina
    Angelopoulou, Efthalia
    Beratis, Ion
    Stamelou, Maria
    Trapali, Xenia Geronicola
    Papageorgiou, Sokratis G.
    Stefanis, Leonidas
    PARKINSONISM & RELATED DISORDERS, 2021, 91 : 1 - 8
  • [10] Reduced LRRK2 in association with retromer dysfunction in post-mortem brain tissue from LRRK2 mutation carriers
    Zhao, Ye
    Perera, Gayathri
    Takahashi-Fujigasaki, Junko
    Mash, Deborah C.
    Vonsattel, Jean Paul G.
    Uchino, Akiko
    Hasegawa, Kazuko
    Nichols, R. Jeremy
    Holton, Janice L.
    Murayama, Shigeo
    Dzamko, Nicolas
    Halliday, Glenda M.
    BRAIN, 2018, 141 : 486 - 495